Lonza snaps up Codiak's exosome manufacturing site for $65M of 'in kind' services
Lonza snapped up Codiak Biosciences' exosome manufacturing facility in Massachusetts, gaining access to technology that turns drug molecules into exosomes in order to selectively deliver treatments to target tissues and reduce toxicity. The two companies are forming a Center of Excellence for the development of exosome production and analytics technologies.
Source: fiercepharma.com